Mineralys Therapeutics, Inc. Common Stock (MLYS) — Defensive Interval Ratio
Mineralys Therapeutics, Inc. Common Stock (MLYS) has a Defensive Interval Ratio of 13225 days as of March 2026. Defensive assets of $533.28 Million (cash $-, short-term investments $533.28 Million, receivables $-) cover 13225 days of daily cash needs of $40.32K/day. See MLYS current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Mineralys Therapeutics, Inc. Common Stock Defensive Interval Ratio (2021–2025)
This chart shows how Mineralys Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 13225 days, meaning defensive assets of $533.28 Million can fund 13225 days of operations without new revenue. See MLYS equity financing ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Mineralys Therapeutics, Inc. Common Stock (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Mineralys Therapeutics, Inc. Common Stock from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see MLYS market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 11682 days | $483.71 Million | $41.41K/day | $- | $483.71 Million | ▲ +9587 days |
| 2024 | 2096 days | $84.10 Million | $40.13K/day | $- | $84.10 Million | ▼ -4425 days |
| 2023 | 6521 days | $187.26 Million | $28.72K/day | $- | $187.26 Million | ▲ +5507 days |
| 2022 | 1014 days | $22.41 Million | $22.10K/day | $- | $22.41 Million | ▲ +1014 days |
| 2021 | 0 days | $0.00 | $13.85K/day | $- | $0.00 | — |